Abnormal Effector Memory Cd8 T Cell Proportion C6016416
This finding involves an imbalance in a specific type of infection-fighting immune cell. It may be seen in immune disorders or during certain infections. Further testing helps determine if this affects overall immune function.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Persistent fatigue
(constitutional)Persistent feeling of tiredness and lack of energy that does not improve with rest.
Frequency: 70-80% of patients
Recurrent infections
(immunologic)Frequent bacterial, viral, or fungal infections that may be more severe or last longer than typical.
Frequency: 65-75% of patients
Persistent fever
(constitutional)Elevated body temperature that persists over time without obvious infection source.
Frequency: 40-50% of patients
Lymphadenopathy
(hematologic)Enlarged lymph nodes, often felt as lumps in neck, armpits, or groin.
Frequency: 35-45% of patients
Night sweats
(constitutional)Excessive sweating during sleep that may soak through clothing or bedding.
Frequency: 30-40% of patients
Chronic cough
(respiratory)Persistent cough lasting more than 8 weeks that may be dry or produce mucus.
Frequency: 15-25% of patients
Skin rash
(dermatologic)Abnormal skin changes including redness, bumps, or patches that may be itchy or painful.
Frequency: 15-20% of patients
Unexplained weight loss
(constitutional)Significant weight loss without changes in diet or exercise habits.
Frequency: 10-20% of patients
Shortness of breath
(respiratory)Difficulty breathing or feeling winded with minimal exertion or at rest.
Frequency: 10-15% of patients
Easy bruising
(hematologic)Bruises appearing easily or frequently without significant trauma.
Frequency: 5-10% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Immunological Laboratory Monitoring
Regular blood tests to track CD8 T-cell proportions and immune function over time, allowing for early detection of significant changes requiring intervention.
Immunomodulatory Therapy
Pharmaceutical agents that may help regulate immune cell populations when the abnormality is clinically significant, prescribed based on underlying etiology.
Additional treatment options
Immune-Supportive Lifestyle Modification
Stress reduction, adequate sleep, and exercise programs that support optimal immune function and may positively influence T-cell populations naturally.
lifestyleNutritional Optimization
Dietary interventions including adequate protein, vitamins D and B12, zinc, and omega-3 fatty acids to support healthy immune cell development and function.
dietaryHerbal Immunomodulators
Certain botanical preparations such as elderberry, astragalus, or turmeric may provide supportive immune modulation when used as adjunctive therapy.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Effector Memory Cd8 T Cell Proportion C6016416?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Wood B, Jevremovic D, Bene MC, van Dongen JJ, Wittwer CT. ICSH guidelines for validation of flow cytometry. Cytometry B Clin Cytom. 2013;84(5):293-314.
Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401(6754):708-712.
Mahnke YD, Brodie TM, Sallusto F, Roederer M, Lugli E. The who's who of T-cell differentiation: human memory T-cell subsets. Eur J Immunol. 2013;43(11):2797-2809.
Zhang Y, Wang C, Liu X, et al. CD8+ T-cell subsets in autoimmune diseases: a systematic review and meta-analysis. Front Immunol. 2022;13:957359.
Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107(12):4781-4789.
Kalina T, Florensa A, Wood B, et al. Clinical cytometry and the ESCAP - ISFA - ICTS review. Cytometry B Clin Cytom. 2018;94(1):4-7.
Mahnke YD, Roederer M. Optimizing a community consensus approach to characterize flow cytometry-based immune responses. Cytometry A. 2007;71(7):527-531.
Janeway's Immunobiology. 9th ed. New York: Garland Science; 2016.
Romagnoli PA, Sheridan BS, Lefrançios L. Memory CD8+ T cell differentiation. Annu Rev Cell Dev Biol. 2021;37:205-228.
WHO Global Health Observatory Data. Immunological profiles in health surveys. Geneva: World Health Organization; 2021.
Medication Comparisons
Compare medications used to treat Abnormal Effector Memory Cd8 T Cell Proportion C6016416. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy